Celldex cancer vaccine meets goal in midstage trial By: Reuters: Company News November 20, 2010 at 07:00 AM EST * Vaccine extends survival time without disease progression Read More >> Related Stocks: Celldex Therapeutics Denbury Resources Pfizer